Growth Late Stage CEO Forum

Growth / Late Growth Stage CEO Forum

A unique, powerful and valuable space for the candid sharing of experience between 40 of the sector’s emerging and innovative post-series A life science executives. Like-minded Executives are joined by 2-3 appropriate and value-matched industry stakeholders and partners to provide expertise, experience and best practice on strategic areas of focus. Case studies will also be delivered by a number of executives in the room who have enjoyed success or navigated key challenges in their pursuit of company growth.

A pre-registration only, exclusive hollow square forum where all participants are active discussants.

Qualifier: Company executives must be post-series A and from a therapeutic-indication Biotech company

Session Outline: 1pm - 3pm and 3.30pm – 5.30pm followed by CEO Drinks and Dinner

Case studies include but not limited to:

  • A keynote presentation with views on investment trends and deal making
  • Case study: considerations for a commercialization model: how to optimize value to patients and stakeholders
  • Case study: taking your products through the clinic / clinical / R&D strategies
  • Case study: internationalization as a strategy to maximise the global potential of clinical pipelines
  • Case study: challenges in securing later stage investment
  • Case study: later-stage licensing deals / partnerships to scale your business
  • Case study: preparing commercial go-to-market, strategies and activities


  • Approx. 20mins of hollow square discussion around each of the above topics
  • 1hr of general macro challenge discussion not restricted to valuation, alternative growth strategies, asset commercial strategies and research partnerships


For enquiries contact:

Matt Pullan, SVP, Business Development 
+44 (0) 203 637 5908